Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma
CA: A Cancer Journal for Clinicians · 2026-05 · 76 (3)
DOI: 10.3322/caac.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 10.06.2026. Verfasst von Kevin Card und 3 weiteren Autor:innen. Beteiligte Einrichtung: Retina and Macular Disease Service, New England Eye Center, Boston, Massachusetts, USA. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Retina and Macular Disease Service, New England Eye Center, Boston, Massachusetts, USA.
- Department of Ophthalmology, Tufts University Medical Center, Boston, Massachusetts, USA.
- Department of Hematology and Oncology, Dana Farber Cancer Institute Boston, Boston, Massachusetts, USA.
- Department of Radiation Oncology, Tufts University Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Kevin Card, Shilpa J Desai
Zitieren
APA
Card, K., Haq, R., Mignano, J., & Desai, S. J. (2026). Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma. CA: A Cancer Journal for Clinicians, 76(3). https://doi.org/10.3322/caac.70091
Vancouver
Card K, Haq R, Mignano J, Desai SJ. Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma. CA: A Cancer Journal for Clinicians. 2026;76(3). doi:10.3322/caac.70091
BibTeX
@article{Card2026,
author = {Card, Kevin and Haq, Rizwan and Mignano, John and Desai, Shilpa J},
title = {Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma},
journal = {CA: A Cancer Journal for Clinicians},
year = {2026},
volume = {76},
number = {3},
doi = {10.3322/caac.70091}
}
EUVIMED